Orla H.
- Country
- Ireland
- Department
- Neurology
Research Overview
- Safety and Tolerability Evaluation of QRL-201 in Patients with Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
- A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Usnoflast in Adults with Amyotrophic Lateral Sclerosis
- Efficacy and Safety of Pridopidine in Participants with Amyotrophic Lateral Sclerosis: A Phase 3, Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 52 of 137 partner sites.
Specializations
Neurodegenerative Disease Focus
This investigator specializes in studying Amyotrophic Lateral Sclerosis (ALS), with particular emphasis on novel therapeutic approaches for managing disease progression.
- Motor Neuron Disease Management
- Disease Progression Assessment
- Survival Rate Analysis
The research extends to evaluating treatments targeting specific genetic mutations in ALS, including FUS-ALS variants.
Clinical Outcomes Research
The investigator focuses on studying therapeutic interventions that address ventilation-free survival and functional outcomes in ALS patients.
- Quality of Life Measures
- Functional Assessment Protocols
- Long-term Survival Metrics
Special attention is given to evaluating treatments that may impact overall survival and daily functioning capabilities.
Therapeutic Development
Research interests include investigating novel therapeutic compounds for ALS treatment, with a focus on disease-modifying approaches.
- Innovative Treatment Strategies
- Clinical Efficacy Assessment
- Treatment Response Monitoring
The work encompasses evaluation of multiple therapeutic candidates targeting different aspects of ALS pathophysiology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.